We are live on ! Find out more
BTCY

Biotricity, Inc. Common Stock

Delisted

BTCY was delisted on the 2nd of August, 2024.

29 hedge funds and large institutions have $11.2M invested in Biotricity, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,891% more capital invested

Capital invested by funds: $564K → $11.2M (+$10.7M)

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

350% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 4

216% more call options, than puts

Call options by funds: $426K | Put options by funds: $135K

93% more funds holding

Funds holding: 1529 (+14)

Holders
29
Holders Change
+14
Holders Change %
+93.33%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
5
Reduced
1
Closed
4
Calls
$426K
Puts
$135K
Net Calls
+$291K
Net Calls Change
+$291K

BTCY Hedge Fund Activity: Q4 2021 in Review

29 of the 6,514 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q4 2021, worth a combined $11.2M — up 1,891% from $564K a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new BTCY positions and 4 closed out — a net gain of 14 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $6.53M. The largest seller was Magnus Financial Group, exiting entirely with an estimated $54K sold.

  • 29 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q4 2021, up from 15 in Q3 2021.
  • Funds reported $11.2M of Biotricity, Inc. Common Stock stock for Q4 2021, up 1,891% quarter-over-quarter.
  • 18 funds opened new Biotricity, Inc. Common Stock positions in Q4 2021 and 4 closed out, a net change of +14 holders.
  • The largest Biotricity, Inc. Common Stock buyer in Q4 2021 was Vanguard Group, an estimated $6.53M added.
  • The largest Biotricity, Inc. Common Stock seller in Q4 2021 was Magnus Financial Group, an estimated $54K sold.

Based on aggregated 13F filings for Q4 2021.